Hippo signaling dysfunction induces cancer cell addiction to YAP.
Hippo signaling dysfunction induces cancer cell addiction to YAP.
复制标题
DOI:
10.1038/s41388-018-0419-5
复制
发表时间:
2018-12
期刊:
影响因子:
8
通讯作者:
Wang W
中科院分区:
文献类型:
--
作者:
Han H;Yang B;Nakaoka HJ;Yang J;Zhao Y;Le Nguyen K;Bishara AT;Mandalia TK;Wang W
Over the past decades, the Hippo has been established as a crucial pathway involved in organ size control and cancer suppression. Dysregulation of Hippo signaling and hyperactivation of its downstream effector YAP are frequently associated with various human cancers. However, the underlying significance of such YAP activation in cancer development and therapy has not been fully characterized. In this study, we reported that the Hippo signaling deficiency can lead to a YAP-dependent oncogene addiction for cancer cells. Through a clinical compound library screen, we identified histone deacetylase (HDAC) inhibitors as putative inhibitors to suppress YAP expression. Importantly, HDAC inhibitors specifically targeted the viability and xenograft tumor growth for the cancer cells in which YAP is constitutively active. Taken together, our results not only establish an active YAP-induced oncogene addiction in cancer cells, but also lay the foundation to develop targeted therapies for the cancers with Hippo dysfunction and YAP activation.
登录
查看更多内容
影响因子:
64.5
作者:
Yu FX;Zhao B;Guan KL
通讯作者:
Guan KL
影响因子:
4.6
作者:
Jung DE;Park SB;Kim K;Kim C;Song SY
通讯作者:
Song SY
影响因子:
16.6
作者:
Meng Z;Moroishi T;Mottier-Pavie V;Plouffe SW;Hansen CG;Hong AW;Park HW;Mo JS;Lu W;Lu S;Flores F;Yu FX;Halder G;Guan KL
通讯作者:
Guan KL
影响因子:
64.5
作者:
Kapoor A;Yao W;Ying H;Hua S;Liewen A;Wang Q;Zhong Y;Wu CJ;Sadanandam A;Hu B;Chang Q;Chu GC;Al-Khalil R;Jiang S;Xia H;Fletcher-Sananikone E;Lim C;Horwitz GI;Viale A;Pettazzoni P;Sanchez N;Wang H;Protopopov A;Zhang J;Heffernan T;Johnson RL;Chin L;Wang YA;Draetta G;DePinho RA
通讯作者:
DePinho RA
影响因子:
50.3
作者:
Zanconato F;Cordenonsi M;Piccolo S
通讯作者:
Piccolo S